{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:16:34Z","timestamp":1794651394960,"version":"4.9.1"},"reference-count":135,"publisher":"The Royal Society","issue":"1623","license":[{"start":{"date-parts":[[2013,8,5]],"date-time":"2013-08-05T00:00:00Z","timestamp":1375660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/royalsociety.org\/journals\/ethics-policies\/data-sharing-mining\/"}],"content-domain":{"domain":["royalsocietypublishing.org"],"crossmark-restriction":true},"short-container-title":["Phil. Trans. R. Soc. B"],"published-print":{"date-parts":[[2013,8,5]]},"abstract":"<jats:p>The global incidence of poliomyelitis has dropped by more than 99 per cent since the governments of the world committed to eradication in 1988. One of the three serotypes of wild poliovirus has been eradicated and the remaining two serotypes are limited to just a small number of endemic regions. However, the Global Polio Eradication Initiative (GPEI) has faced a number of challenges in eradicating the last 1 per cent of wild-virus transmission. The polio endgame has also been complicated by the recognition that vaccination with the oral poliovirus vaccine (OPV) must eventually cease because of the risk of outbreaks of vaccine-derived polioviruses. I describe the major challenges to wild poliovirus eradication, focusing on the poor immunogenicity of OPV in lower-income countries, the inherent limitations to the sensitivity and specificity of surveillance, the international spread of poliovirus and resulting outbreaks, and the potential significance of waning intestinal immunity induced by OPV. I then focus on the challenges to eradicating all polioviruses, the problem of vaccine-derived polioviruses and the risk of wild-type or vaccine-derived poliovirus re-emergence after the cessation of oral vaccination. I document the role of research in the GPEI's response to these challenges and ultimately the feasibility of achieving a world without poliomyelitis.<\/jats:p>","DOI":"10.1098\/rstb.2012.0140","type":"journal-article","created":{"date-parts":[[2013,6,24]],"date-time":"2013-06-24T21:27:42Z","timestamp":1372109262000},"page":"20120140","update-policy":"https:\/\/doi.org\/10.1098\/crossmark-policy","source":"Crossref","is-referenced-by-count":70,"title":["The final stages of the global eradication of poliomyelitis"],"prefix":"10.1098","volume":"368","author":[{"given":"Nicholas C.","family":"Grassly","sequence":"first","affiliation":[{"name":"Department of Infectious Disease Epidemiology, Imperial College London, Norfolk Place, London W2 1PG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"175","published-online":{"date-parts":[[2013,8,5]]},"reference":[{"key":"e_1_3_2_2_2","first-page":"311","article-title":"Can post-eradication laboratory containment of wild polioviruses be achieved?","volume":"80","author":"Dowdle WR","year":"2002","journal-title":"Bull. WHO"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009924"},{"key":"e_1_3_2_4_2","volume-title":"Global eradication of poliomyelitis by the year 2000. Forty-first World Health Assembly resolution WHA41.28","author":"Wor","year":"1988"},{"key":"e_1_3_2_5_2","first-page":"651","volume-title":"Vaccines","author":"Sutter RW","year":"2008","edition":"5"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196810242791701"},{"key":"e_1_3_2_7_2","unstructured":"World Health Organisation. 2012 Polio Case Count. See http:\/\/apps.who.int\/immunization_monitoring\/en\/diseases\/poliomyelitis\/case_count.cfm. (Accessed 19 September 2012)."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1068284"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0910074"},{"key":"e_1_3_2_10_2","first-page":"401","article-title":"Conclusions and recommendations of the Ad Hoc Advisory Committee on Poliomyelitis Eradication, Geneva, 21\u201322 September 2004","volume":"79","author":"Wo","year":"2004","journal-title":"Wkly. Epidemiol. Rec."},{"key":"e_1_3_2_11_2","first-page":"79","article-title":"Paralytic poliomyelitis\u2014United States, 1980\u20131994","volume":"46","author":"Centers for Disease Control and Prevention","year":"1997","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"e_1_3_2_12_2","first-page":"367","article-title":"Studies on the development of natural immunity to poliomyelitis in Louisiana II. Description and analysis of infection observed in study group households","volume":"65","author":"Gelfand HM","year":"1957","journal-title":"Am. J. Hyg."},{"key":"e_1_3_2_13_2","first-page":"207","article-title":"Development of neutralizing antibodies against the three types of poliomyelitis virus during an epidemic period","volume":"58","author":"Melnick JL","year":"1953","journal-title":"Am. J. Hyg."},{"key":"e_1_3_2_14_2","first-page":"195","article-title":"The paralytic\/infected ratio in a susceptible population during a polio type I epidemic","volume":"39","author":"Penttinen K","year":"1961","journal-title":"Ann. Med. Exp. Biol. Fenn."},{"key":"e_1_3_2_15_2","first-page":"215","article-title":"Vaccination with the CHAT strain of type 1 attenuated poliomyelitis virus in Leopoldville, Belgian Congo","volume":"22","author":"Plotkin SA","year":"1960","journal-title":"Bull. WHO"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/13.5.926"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1130388"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2006.03.011"},{"key":"e_1_3_2_19_2","first-page":"179","article-title":"Community-wide use of a \u2018balanced\u2019 trivalent oral poliovirus vaccine (Sabin)","volume":"53","author":"Robertson HE","year":"1962","journal-title":"A report of the 1961 trial at Prince Albert, Saskatchewan. Can. J. Public Health"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01720298"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/6.Supplement_2.S413"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60531-5"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0800390"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0803259"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60648-5"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61230-5"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13312-012-0018-4"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1086\/321905"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/6.Supplement_2.S400"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/6.Supplement_2.S408"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001109"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.10.005"},{"key":"e_1_3_2_33_2","unstructured":"Independent Monitoring Board of the Global Polio Eradication Initiative. 2012 Fifth report. Available at www.polioeradication.org. (Accessed 1 October 2012)."},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040073"},{"key":"e_1_3_2_35_2","unstructured":"Global Polio Eradication Initiative. 2012 GPEI Financial Resource Requirements. See http:\/\/www.polioeradication.org\/Financing.aspx. (Accessed 1 October 2012)."},{"key":"e_1_3_2_36_2","unstructured":"Jafari H. 2012 Prioritizing emergency polio eradication activities managing the financing gap \u2013 the other half of the emergency . See http:\/\/www.who.int\/immunization\/sage\/meetings\/2012\/april\/en\/. (Accessed 2 October 2012)."},{"key":"e_1_3_2_37_2","unstructured":"Independent Monitoring Board of the Global Polio Eradication Initiative. 2011 Third report. See www.polioeradication.org. (Accessed 1 October 2012)."},{"key":"e_1_3_2_38_2","unstructured":"World Health Organisation. 2012 Poliomyelitis: intensification of the global eradication initiative. 65th World Health Assembly resolution WHA65.5 . Geneva Switzerland: WHO."},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1080\/10810731003695375"},{"key":"e_1_3_2_40_2","first-page":"330","article-title":"Eradication of poliomyelitis in countries affected by conflict","volume":"78","author":"Tangermann RH","year":"2000","journal-title":"Bull. World Health Organ."},{"key":"e_1_3_2_41_2","first-page":"61","volume-title":"The eradication of infectious diseases","author":"Aylward RB","year":"1998"},{"key":"e_1_3_2_42_2","first-page":"19","volume-title":"Polio global eradication initiative: strategic plan 2010\u20132012","author":"Worl","year":"2010"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.epirev.a018041"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/21.4.800"},{"key":"e_1_3_2_45_2","first-page":"967","article-title":"Laboratory surveillance for wild and vaccine-derived polioviruses\u2014worldwide, January 2007\u2013June 2008","volume":"57","author":"Centers for Disease Control and Prevention","year":"2008","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"e_1_3_2_46_2","first-page":"265","article-title":"Tracking progress toward global polio eradication, 2010\u20132011","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91442-W"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a008820"},{"key":"e_1_3_2_49_2","unstructured":"Global Polio Eradication Initiative. 2011 Responding to a polio outbreak: guideline . See http:\/\/www.polioeradication.org\/Portals\/0\/Document\/Resources\/PolioEradicators\/1a.PolioOutbreakGuideline20110107.pdf. (Accessed 2 October 2012). Geneva Switzerland: WHO."},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02354-07"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1044-5773(05)80017-4"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.03.034"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-9-51"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwg202"},{"key":"e_1_3_2_55_2","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1128\/JCM.37.6.1670-1675.1999","article-title":"Detection of poliovirus circulation by environmental surveillance in the absence of clinical cases in Israel and the Palestinian Authority","volume":"37","author":"Manor Y","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365549209052605"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21230"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268801005787"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.69.5.2919-2927.2003"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.watres.2005.05.027"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2010.02.014"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000069"},{"key":"e_1_3_2_63_2","volume-title":"Fifteenth Informal Consultation of the Global Polio Laboratory Network","author":"W","year":"2009"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.00535-07"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.02764-07"},{"key":"e_1_3_2_66_2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2807\/ese.15.19.19566-en","article-title":"Highly divergent neurovirulent vaccine-derived polioviruses of all three serotypes are recurrently detected in Finnish sewage","volume":"15","author":"Roivainen M","year":"2010","journal-title":"Eurosurveillance"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis714"},{"key":"e_1_3_2_68_2","unstructured":"Grassly NC (ed). 2009 Poliomyelitis outbreaks in countries previously free of wild poliovirus. Meeting of the WHO Strategic Advisory Group of Experts on Immunisation Geneva 27\u201329 October 2009 . Presentation available at http:\/\/www.who.int\/immunization\/sage\/GrasslySAGEOct09.pdf. (Accessed 4 October 2012)."},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1959.03010170001001"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/175.Supplement_1.S86"},{"key":"e_1_3_2_71_2","first-page":"195","article-title":"Poliomyelitis epidemic in the Netherlands, 1978","volume":"43","author":"Bijkerk H","year":"1979","journal-title":"Dev. Biol. Stand."},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)91566-7"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268800052195"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0022172400040389"},{"key":"e_1_3_2_75_2","first-page":"265","article-title":"Comparison of the resistance of the intestinal tract to poliomyelitis virus (Sabin's strains) in persons after naturally and experimentally acquired immunity","volume":"5","author":"Ghendon YZ","year":"1961","journal-title":"Acta Virol."},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis241"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1086\/651952"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23184"},{"key":"e_1_3_2_79_2","volume-title":"Measles and Poliomyelitis","author":"Sutter RW","year":"1993"},{"key":"e_1_3_2_80_2","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.4049\/jimmunol.162.8.5011","article-title":"Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus","volume":"162","author":"Herremans TM","year":"1999","journal-title":"J. Immunol."},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","DOI":"10.1006\/biol.1993.1096"},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1038\/314548a0"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-67-4-693"},{"key":"e_1_3_2_84_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-69-5-1091"},{"key":"e_1_3_2_85_2","doi-asserted-by":"crossref","first-page":"7758","DOI":"10.1128\/JVI.71.10.7758-7768.1997","article-title":"Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis","volume":"71","author":"Georgescu MM","year":"1997","journal-title":"J. Virol."},{"key":"e_1_3_2_86_2","volume-title":"The association of cases of poliomyelitis with the use of type 3 oral poliomyelitis vaccines","author":"Terry L","year":"1962"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/14.2.568"},{"key":"e_1_3_2_88_2","first-page":"33","article-title":"Risk of vaccine-associated paralytic poliomyelitis in Latin-America, 1989\u201391","volume":"73","author":"Andrus JK","year":"1995","journal-title":"Bull. WHO"},{"key":"e_1_3_2_89_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.15.8366-8377.2003"},{"key":"e_1_3_2_90_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.micro.58.030603.123625"},{"key":"e_1_3_2_91_2","first-page":"358","article-title":"Update on vaccine-derived polioviruses detected worldwide, April 2011\u2013June 2012","volume":"87","author":"Wo","year":"2012","journal-title":"Wkly Epidemiol. Rec."},{"key":"e_1_3_2_92_2","unstructured":"Circulating vaccine-derived poliovirus (cVDPV) 2000\u20132012. See http:\/\/www.polioeradication.org\/Dataandmonitoring\/Poliothisweek\/Circulatingvaccinederivedpoliovirus.aspx. (Accessed 8 October 2012)."},{"key":"e_1_3_2_93_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0030191"},{"key":"e_1_3_2_94_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis204"},{"key":"e_1_3_2_95_2","doi-asserted-by":"publisher","DOI":"10.1086\/525049"},{"key":"e_1_3_2_96_2","first-page":"349","article-title":"Progress towards global poliomyelitis eradication: preparation for the oral poliovirus vaccine cessation era","volume":"79","author":"Worl","year":"2004","journal-title":"Wkly Epidemiol. Rec."},{"key":"e_1_3_2_97_2","volume-title":"Cessation of routine oral polio vaccine (OPV) use after global polio eradication: framework for national policy makers in OPV-using countries","author":"World Health Organisation","year":"2005"},{"key":"e_1_3_2_98_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/30.5.1029"},{"key":"e_1_3_2_99_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyg185"},{"key":"e_1_3_2_100_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1960.03020320001001"},{"key":"e_1_3_2_101_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66386-6"},{"key":"e_1_3_2_102_2","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/pis062"},{"key":"e_1_3_2_103_2","first-page":"1","article-title":"Meeting of the strategic advisory group of experts on immunization, November 2011\u2014conclusions and recommendations","volume":"87","author":"World Health Organisation","year":"2012","journal-title":"Wkly Epidemiol. Rec."},{"key":"e_1_3_2_104_2","unstructured":"SAGE Polio Working Group. 2012 Proposed policy for a global switch from \u2018tOPV to bOPV\u2019 for routine immunization. See http:\/\/www.who.int\/immunization\/sage\/meetings\/2012\/april\/2_Polio_WG_background_paper_26_Mar2012.pdf. (Accessed 8 October 2012)."},{"key":"e_1_3_2_105_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2006.00827.x"},{"key":"e_1_3_2_106_2","first-page":"2316","article-title":"Vaccine-derived poliomyelitis 12 years after infection in Minnesota","volume":"2364","author":"DeVries AS","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_107_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.9.4876-4883.2004"},{"key":"e_1_3_2_108_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.06.017"},{"key":"e_1_3_2_109_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1607.091606"},{"key":"e_1_3_2_110_2","first-page":"3","article-title":"Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom","volume":"82","author":"Halsey NA","year":"2008","journal-title":"Bull. WHO"},{"key":"e_1_3_2_111_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2008.04.002"},{"key":"e_1_3_2_112_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2006.00844.x"},{"key":"e_1_3_2_113_2","volume-title":"WHO global action plan to minimize poliovirus facility-associated risk after eradication of wild polioviruses and cessation of routine OPV use","author":"Worl","year":"2009"},{"key":"e_1_3_2_114_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir723"},{"key":"e_1_3_2_115_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00370-06"},{"key":"e_1_3_2_116_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00508-09"},{"key":"e_1_3_2_117_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1155761"},{"key":"e_1_3_2_118_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1072266"},{"key":"e_1_3_2_119_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0700451104"},{"key":"e_1_3_2_120_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2006.00855.x"},{"key":"e_1_3_2_121_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002599"},{"key":"e_1_3_2_122_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00523-6"},{"key":"e_1_3_2_123_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/175.Supplement_1.S215"},{"key":"e_1_3_2_124_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/6.Supplement_2.S467"},{"key":"e_1_3_2_125_2","first-page":"137","article-title":"Inactivated poliovirus vaccine following oral poliovirus vaccine cessation","volume":"81","author":"Worl","year":"2006","journal-title":"Wkly Epidemiol. Rec."},{"key":"e_1_3_2_126_2","doi-asserted-by":"publisher","DOI":"10.1086\/651611"},{"key":"e_1_3_2_127_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909383"},{"key":"e_1_3_2_128_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2011.10.002"},{"key":"e_1_3_2_129_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70190-6"},{"key":"e_1_3_2_130_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.11.043"},{"key":"e_1_3_2_131_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.08.047"},{"key":"e_1_3_2_132_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/6.Supplement_2.S444"},{"key":"e_1_3_2_133_2","first-page":"201","article-title":"Meeting of the strategic advisory group of experts on immunization, April 2012\u2014conclusions and recommendations","volume":"87","author":"World Health Organisation","year":"2012","journal-title":"Wkly Epidemiol. Rec."},{"key":"e_1_3_2_134_2","unstructured":"World Health Organisation. 2012 Meeting of the Strategic Advisory Group of Experts on Immunization November 2012\u2014conclusions and recommendations. News report. See http \/\/www.who.int\/immunization\/sage\/meetings\/2012\/november\/news_sage_ipv_opv_nov2012\/en\/index.html. (Accessed 4 December 2012)."},{"key":"e_1_3_2_135_2","doi-asserted-by":"publisher","DOI":"10.4161\/hv.18630"},{"key":"e_1_3_2_136_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2012.02.006"}],"container-title":["Philosophical Transactions of the Royal Society B: Biological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/royalsocietypublishing.org\/doi\/pdf\/10.1098\/rstb.2012.0140","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/royalsocietypublishing.org\/doi\/full-xml\/10.1098\/rstb.2012.0140","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/royalsocietypublishing.org\/doi\/pdf\/10.1098\/rstb.2012.0140","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:21:00Z","timestamp":1778620860000},"score":1,"resource":{"primary":{"URL":"http:\/\/royalsocietypublishing.org\/rstb\/article\/22196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,5]]},"references-count":135,"journal-issue":{"issue":"1623","published-print":{"date-parts":[[2013,8,5]]}},"alternative-id":["10.1098\/rstb.2012.0140"],"URL":"https:\/\/doi.org\/10.1098\/rstb.2012.0140","relation":{},"ISSN":["0962-8436","1471-2970"],"issn-type":[{"value":"0962-8436","type":"print"},{"value":"1471-2970","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,5]]},"assertion":[{"value":"2013-08-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}